References
- Wright J L, Cobb J P, Gumport S L, et al. Investigation of the relation between clinical and tissue culture response to chemotherapeutic agents of human cancer. N Engl J Med 1957; 252: 1207–1211
- Plummer-Cobb J, Walker D G, Wright J C. Comparative chemotherapy studies on primary short-term cultures of human normal benign and malignant tumor tissues—a five-year study. Cancer Res 1961; 21: 583–590
- Roper P, Drewinko B. Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res 1976; 36: 2182–2188
- Black M M, Speer F D. Further observaions on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue. J Natl Cancer Inst 1954; 14: 1147–1158
- DiPaolo J A, Dowd J E. Evaluation of inhibition of human tumor tissue by cancer chemotherapeutic drugs with an in vitro test. J Natl Cancer Inst 1961; 27: 807–815
- Mossmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cell cytotoxicity assays. J Immunol Methods 1983; 65: 51–63
- Bickis I J, Henderson M D, Quastel J H. Biochemical studies of human tumors. D. In vitro estimation of individual tumor sensitivity to anticancer agents. Cancer 1966; 19: 103–113
- Volm M, Wayss K, Kaufmann M, Mattern J. Pretherapeutic detection of tumor resistance and the results of tumor chemotherapy. Eur J Cancer 1979; 15: 983–993
- Silverstrini R. Experimental approaches to improve the clinical management of rumors. Chemother Oncol 1981; 5: 14–20
- Wolberg W H. Response of DNA thymine synthesis in human tumor and normal tissue to 5-fluorouracil. Cancer Res 1972; 32: 130–132
- Steel G G. Growth Kinetics of Tumours. Oxford University Press, London 1977; 217–267
- Park C H, Bergasgel D E, McCulloch E A. Mouse myeloma tumor stem cells: A primary cell culture assay. J Natl Cancer Inst 1971; 46: 411–422
- Ogawa M, Bergsagel D E, McCulloch E A. Chemotherapy of mouse myeloma: Quantitative cell culture predictive of response in vivo. Blood 1973; 41: 7–15
- Steel G G, Adams K, Stephens T C. Clonogenic assays in B16 melanoma: Response to cyclophosphamide. Br J Cancer, 36: 618–624
- Hamburger A W, Salmon S E. Primary bioassay of human myeloma cells. J Clin Invest 1977; 60: 846–854
- Hamburger A W, Salmon S E. Primary bioassay of human tumor stem cells. Science 1977; 197: 461–463
- Salmon S E, Hamburger A W, Soehnlen B. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 1978; 298: 1321–1327
- Von Hoff D D. Send this patient's tumor for culture and sensitivity. N Engl J Med 1983; 308: 154–155
- Lieber M M. Technical problems with soft agar colony formation assays for in vitro chemosensitivity testing of human solid tumors: Mayo Clinic experience. Rec Results Cancer Res 1984; 94: 51–55
- Weisenthal L M, Lippman M E. Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat Rep 1985; 69: 615–632
- Weisenthal L M, Marsden J A, Dill P L, et al. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 1983; 43: 749–757
- Gazdar A, Steinberg S M, Russell, et al. Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive small cell lung cancer. A prospective clinical trial. J Natl Cancer Inst 1990; 82: 117–124
- Scudicro D, Shoemaker P H, Paull K D, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res, 48: 4827–4833
- Holder H T, Lichter W, Sigel M. Quantitative methods for measuring cell growth and death. Tissue Culture, P F Kruse, M R Patterson. Academic Press, New York 1977; 408–412
- Rotman B, Papermaster B W. Membrane properties of living mammalian cells as studied by enzymatic hydroloysis of fluorogenic esters. Proc Natl Acad Sci (USA) 1966; 55: 134–141
- Rotman B, Teptitz C, Dickinson R, Cozzolino J P. Individual human tumors in short-term micro-organ cultures: Chemosensitivity testing by fluorescent cytoprinting. In Vitro Cell Dev Biol 1988; 24: 1137–1146
- Ross D D, Joneckis S C, Ordonez J, et al. Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number. Cancer Res 1989; 49: 3776–3782
- Sanfilippo O, Silverstrini R, Zaffaroni N, et al. Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity. Cancer 1986; 58: 1441–1447
- Freeman A E, Hoffman R M. In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci (USA) 1986; 83: 2694–2698
- Vescio R A, Connors R M, Youngkin T, et al. Cancer biology for individualized therapy: Correlation of growth fraction index in native-state histoculture with tumor grade and stage. Proc Natl Acad (USA) 1990; 87: 691–695
- Maurer H R, Ali-Osman F. Tumor stem cell cloning in agar containing capillaries. Naturwillenschaften 1981; 68: 381–383
- Von Hoff D D, Forseth B J, Huong M, et al. Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes. Cancer Res 1986; 46: 4012–4017
- Shoemaker R H, Wolpert-DeFilipes M K, Kern D H, et al. Application of a human tumor colony-forming assay to new drug screening. Cancer Res 1985; 45: 2145–2153
- Tanigawa N, Kern D H, Hikasa Y, et al. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 1982; 42: 2159–2164
- Von Hoff D. “He's not going to talk about in vitro predictive assays again is he?”. J Natl Cancer Inst 1990; 82: 96–101
- Baker F, Spitzer G, Ajani J. Successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented media. Drug and radiation sensitivity measurements. Cancer Res 1986; 46: 1263–1274
- Ajani J, Baker F L, Spitzer G, et al. Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system. J Clin Oncol 1987; 5: 1912–1921
- Von Hoff D D, Sandbach J F, Clark G M, et al. Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Inst 1990; 82: 110–116
- Welander C E, Morgan T M, Homesly H D. Multiple factors predicting responders to combination chemotherapy in patients with ovarian cancer. Human Tumor Cloning, S E Salmon, J M Trent. Grime & Stratton, Orlando 1984; 521–534
- Salmon S E. Improved methodology for chemosensitivity testing. J Clin Oncol 1987; 5: 1861–1853
- Von Hoff D D. In vitro predictive testing. The sulfonamide era. Int J Cell Cloning 1987; 5: 179–190